이글벳 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 강승조, was filed 11 Apr 2023.
이글벳: what insiders have been doing
이글벳, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). Nothing new has been filed by managers of 이글벳 in twelve months, the latest record being from 11 April 2023.
Over the whole record (from 2021), the tally stands at 2 purchases and 4 sales.
For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ●Executives0DART
- 100,000 sharesShareKRXDART:20230411002873
- 100,000 sharesShareKRXDART:20230411002858Canonical exit: 10 Jul 2023 (T+90)
- 67 sharesKRXDART:20230331000511
- 10,655 sharesShareKRXDART:20221013000111
- 10,588 sharesKRXDART:20221013000108
- 67 sharesShareKRXDART:20221013000112Canonical exit: 3 Jan 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
10 of 10 declarations
About 이글벳
이글벳 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and distribution of pharmaceutical and healthcare products.
